New York Lymphoma Rounds: Marginal Zone Edition
This special edition of Lymphoma Rounds will feature case presentations on Marginal Zone lymphoma, and will be held in conjunction with the Foundation’s Marginal Zone Lymphoma Scientific Workshop.
Marriott East Side Hotel (click here for directions)
525 Lexington Avenue at East 49th St.
New York, NY 10017
Wednesday, April 17, 2019
6:00 PM – 9:00 PM
Morton Coleman, MD
Weill Cornell Medicine
Francesca Montanari, MD
Columbia University Medical Center
David Straus, MD
Memorial Sloan Kettering Cancer Center
|6:00 PM||Registration and Dinner Buffet|
|6:45 PM||Welcome and Introduction|
|Peggy Ann Torney, MD, Lymphoma Research Foundation|
|7:00 PM||Opening Remarks|
|Morton Coleman, MD, Weill Cornell Medicine and|
Thomas Habermann, MD, Mayo Clinic
|7:20 PM||Ocular Marginal Zone Lymphoma|
|Francesca Montanari, MD, Columbia University Medical Center|
|7:50 PM||Pulmonary Marginal Zone Lymphoma|
|David Straus, MD, Memorial Sloan Kettering Cancer Center|
|John Allan, MD, Weill Cornell Medicine and|
Peter Martin, MD, Weill Cornell Medicine
|Morton Coleman, MD, Weill Cornell Medicine|
|8:50 PM||Concluding Remarks|
Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, LRF, at firstname.lastname@example.org. Exhibit opportunities are also available, however, space is limited.
Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Piper Harmon (email@example.com) at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.
ABOUT THE PROGRAM
The Lymphoma Research Foundation’s New York Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Greater New York City area.
At the conclusion of this educational activity, the participant should be better able to:
- Summarize the latest developments in lymphoma diagnosis, treatment and management.
- Apply best practices for treating lymphoma patients.
- Inform patients about potential clinical trial opportunities.
- Establish a network of health care professionals who work with lymphoma patients.
Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education
This activity is supported by educational grants from:
AbbVie Inc., Celgene Corporation, Genentech, Novartis, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem Oncology
The Lymphoma Research Foundation is pleased to support the Great Debates & Updates in Hematologic Malignancies meeting series, which is fast-approaching. In this 2-day, debate-style series, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology. Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately. Now located in two cities, the west coast meeting will take place in Los Angeles on March 22-23, with its east coast edition being held in New York City on April 5-6. Visit greatdebatesinhema.com for details and use code “ENDORSER” for $50 off registration.